Serum vascular adhesion protein-1 is associated with twelve-year risk of incident cancer, cancer mortality, and all-cause mortality: a community-based cohort study

Chen, Szu-ChiSzu-ChiChenKANG-CHIH FANI WENG YENYang, Chung-YiChung-YiYangCHIA-HUNG LINHsu, Chih-YaoChih-YaoHsuLyu, Ya-PinYa-PinLyuJuan, Hsien-ChiaHsien-ChiaJuanLin, Heng-HueiHeng-HueiLinMAO-SHIN LINSHYANG-RONG SHIHHUNG-YUAN LIKuo, Chun-HengChun-HengKuo2024-01-082024-01-0820232234-943Xhttps://scholars.lib.ntu.edu.tw/handle/123456789/638250Vascular adhesion protein-1 (VAP-1), a dual-function glycoprotein, has been reported to play a crucial role in inflammation and tumor progression. We conducted a community-based cohort study to investigate whether serum VAP-1 could be a potential biomarker for predicting incident cancers and mortality.enall-cause mortality; cancer; cancer incidence; cancer mortality; vascular adhesion protein-1[SDGs]SDG3Serum vascular adhesion protein-1 is associated with twelve-year risk of incident cancer, cancer mortality, and all-cause mortality: a community-based cohort studyjournal article10.3389/fonc.2023.1308353381624792-s2.0-85180893290https://api.elsevier.com/content/abstract/scopus_id/85180893290